Project Grant R01MH134006

Award Date 7/12/24
Completion Date 4/30/29
Dollars Obligated $2.1M
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
The National Institute of Mental Health (NIMH) awarded a $196,875 Project Grant (CFDA 93.242 - Mental Health Research Grants) to The Ohio State University to conduct research on "Digital Monitoring of Emotion Regulation and Suicidal Ideation Among Individuals at Clinical High Risk for Psychosis". The 2-year study aims to examine emotion regulation as a mechanism for suicidal ideation in individuals at clinical high risk for psychosis, using ecological momentary assessment, wearable...
This Project Grant award of $1,135,986, provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), supports research to clarify suicide risk phenotypes among preteen youth aged 8-12 years old. The primary objectives are to: Adapt an existing measure of suicide risk for use with preteens, incorporating expert and stakeholder input to ensure cultural and developmental appropriateness. Use the new measure to establish phenotypes of...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $178,319 to the University of California, San Diego to develop and test a personalized suicide prevention intervention called PRECISE. The project aims to leverage intensive longitudinal data and network science techniques to tailor evidence-based treatments, such as safety planning and dialectical behavior therapy skills, to individual clients...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $661,237 over 5 years to The Ohio State University to conduct research on optimizing brief coping skills interventions for suicide prevention. The study aims to intensively characterize the contexts in which patients at high risk for suicide are most likely to use and benefit from their safety planning interventions, leveraging technology and...
The National Institute of Mental Health (NIMH) awarded a $2,809,928 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the University of Pittsburgh to conduct a multi-site, double-blind, randomized-controlled efficacy trial of a transdiagnostic intervention for sleep and circadian dysfunction to improve depression symptoms in older adults with high suicide risk. The study aims to confirm the target engagement and efficacy of this intervention, as well as develop an algorithm to...
This federal Project Grant award from the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) provides $976,424 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct a randomized controlled trial of a preventive behavioral intervention called Resilience Training (RT) for young adults with psychotic experiences. The study aims to evaluate whether RT can reduce psychotic experiences, anxiety, depression, and...
This $793,161 Project Grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a 5-year experimental study to investigate the relationship between nocturnal wakefulness and suicide risk factors. The University of Arizona, the prime awardee, will recruit 90 adults with recent suicidal ideation to participate in laboratory-based assessments of cognitive processes and affect at different times of day, as well as...
The National Institute of Mental Health (NIMH) awarded Emory University a Project Grant under the Mental Health Research Grants (CFDA 93.242) program to develop advanced prediction models that integrate social factors, specifically loneliness and social isolation, through longitudinal electronic health record (EHR) phenotyping. The $247,894 award, with a project period from November 2024 to October 2026, aims to: 1) develop and validate a tool to identify linguistic markers of loneliness and...
This Project Grant award of $1,549,649.37 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program supports a research project titled "Multimodal Assessment of Social Disconnection as a Proximal Risk for Suicide Ideation in Late Life." The project aims to leverage a multimodal assessment of behavioral and social mechanisms to identify predictors relating social disconnection to suicidal ideation in older adults. Key activities...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), supports a study entitled "Ambulatory Assessment of Glucose Regulation in Suicidal Thoughts and Behaviors." The $201,852 award to Butler Hospital, a division of Care New England Health System, will fund a 5-year study to examine how ambulatory glucose regulation relates to suicidal thoughts and behaviors in daily life. The study aims to enroll 110...

EMOTION REACTIVITY, COGNITIVE REAPPRAISAL, AND SUICIDAL IDEATION IN MIDDLE-AGED AND OLDER ADULTS AT HIGH SUICIDE RISK - ABSTRACT THE GOAL OF THIS PROJECT IS TO EVALUATE THE TEMPORAL AND PREDICTIVE ASSOCIATION OF EMOTION REACTIVITY (ER) AND COGNITIVE REAPPRAISAL (CR) (A WELL-STUDIED EMOTION REGULATION STRATEGY) WITH INTENSITY AND DURATION OF SUICIDAL IDEATION (SI) IN MIDDLE-AGED AND OLDER ADULTS FOLLOWING THEIR DISCHARGE FROM A SUICIDE-RELATED HOSPITALIZATION, A PERIOD OF HIGH SUICIDE RISK. OUR PRELIMINARY EVENT RELATED POTENTIAL (ERP) AND SELF-REPORTED AFFECT DATA ON MIDDLE-AGED : A) INCREASED ER AND REDUCED CR AT DISCHARGE WERE INDEPENDENTLY ASSOCIATED WITH INCREASED INTENSITY AND LONGER DURATION OF SUICIDAL IDEATION AT WEEK 6; AND B) PATIENTS WITH COMBINED HIGH ER AND LOW CR AT DISCHARGE HAD HIGHER INTENSITY AND LONGER DURATION OF SUICIDAL IDEATION AT WEEK 6 THAN THE REST OF THE PATIENTS. AND OLDER ADULTS (N=36) WHO WERE HOSPITALIZED FOR SUICIDALITY DEMONSTRATED THAT WE WILL RECRUIT 162 MIDDLE-AGED AND OLDER ADULTS (40-90 YEARS OLD) WHO HAVE BEEN HOSPITALIZED FOR SUICIDAL IDEATION OR SUICIDAL BEHAVIOR [COLUMBIA SUICIDE SEVERITY RATING SCALE (C-SSRS) AT ADMISSION > 1, I.E., 1=WISHES TO BE DEAD]. WE WILL FOLLOW THE PARTICIPANTS FOR 6 MONTHS AFTER DISCHARGE. SUICIDAL IDEATION AND BEHAVIOR WILL BE MEASURED WEEKLY THROUGH AN INTERVIEWER-ADMINISTERED INSTRUMENT (C-SSRS). ER AND CR WILL BE ASSESSED WITH: 1) ELECTROCORTICAL MEASURES (LATE POSITIVE POTENTIAL) AND SELF-REPORTED AFFECT DURING AN EMOTION REACTIVITY AND REGULATION EEG TASK (PRIMARY MEASURES), AND 2) THE EMOTION REGULATION QUESTIONNAIRE AND THE PERTH EMOTIONAL REACTIVITY SCALE (SECONDARY MEASURES). ASSESSMENTS WILL BE CONDUCTED AT ADMISSION (WITHOUT EEG), DISCHARGE, AND AT WEEKS 6, 12, 18, AND 24. 1. EXAMINE THE INDEPENDENT EFFECTS OF ER AND CR ON INTENSITY AND DURATION OF SI. 2. EXAMINE THE COMBINED EFFECTS OF ER AND CR ON INTENSITY AND DURATION OF SI. EXPLORATORY ANALYSES: 1. EXAMINE WHETHER DEMOGRAPHIC VARIABLES, DISCHARGE CLINICAL CHARACTERISTICS, REHOSPITALIZATION, MEDICAL COMORBIDITIES, AND OTHER SUICIDE RISK FACTORS MODERATE THE RELATIONSHIP OF ER AND CR WITH SUICIDAL IDEATION. 2. EXAMINE ASSOCIATION OF THE LONGITUDINAL PROFILE OF ER AND CR WITH THE LONGITUDINAL PROFILE OF INTENSITY AND DURATION OF SUICIDAL IDEATION. PRIMARY AIMS: THIS IS THE FIRST STUDY TO EXAMINE THE PREDICTIVE RELATIONSHIP OF ER AND CR WITH SUICIDAL IDEATION IN MIDDLE-AGED AND OLDER ADULTS AT HIGH SUICIDE RISK. UNDERSTANDING THIS RELATIONSHIP WILL HELP IDENTIFY: A) MECHANISMS WHICH INCREASE SUICIDAL IDEATION, AND B) SUBGROUPS OF PATIENTS AT INCREASED SUICIDE RISK. CONSISTENT WITH THE CONCEPT OF "PRECISION MEDICINE", THE FINDINGS MAY CONTRIBUTE TO THE DEVELOPMENT OF PERSONALIZED PSYCHOSOCIAL INTERVENTIONS FOR THIS POPULATION.

Posted 7/12/24